Hemlibra Effective at Controlling Bleeds in Acquired Hemophilia
One-month treatment with Hemlibra (emicizumab) and an immunosuppressive medication were effective for patients with acquired hemophilia at rapidly…
Articles by Teresa Carvalho, MS
Transition to Hemlibra Safe, Effective in Children With Hemophilia A
Switching to Hemlibra (emicizumab) was safe and effective in children with hemophilia A, including in those who had…
Rebinyn Approved in US as Routine Preventive Treatment for Hem B
The U.S. Food and Drug Administration has approved Novo Nordisk’s Rebinyn (nonacog beta pegol) as a routine preventive…
Low Red Blood Cells, Clotting Factor Levels Tied to Surgery Bleeding Risk
Hemophilia patients with a low number of red blood cells and reduced coagulation factor levels — the activity level…
#RAREis Representation Program Promotes Equity, Diversity
Horizon Therapeutics has launched its #RAREis Representation program aimed at increasing diversity, equity, and inclusion among patients with rare diseases.
GreenGene F, Next-gen Hemophilia A Treatment, Approved in China
GreenGene F (beroctocog alfa), a lab-made version of coagulation factor VIII, has been approved by regulators in China for…